LEADER 01378nam 2200337 n 450 001 996388852203316 005 20221108074048.0 035 $a(CKB)1000000000636475 035 $a(EEBO)2240890329 035 $a(UnM)99843025 035 $a(EXLCZ)991000000000636475 100 $a19910613d1623 uy | 101 0 $alat 135 $aurbn||||a|bb| 200 00$aOratio qua? auspicatissimum serenissimi principis Caroli, reditum ex Hispanijs celebrauit Georgius Herbert Academię Cantabrigiensis orator$b[electronic resource] 210 $a[Cambridge] $cEx officina Cantrelli Legge, almę matris Cantabrigię typographi$d1623 215 $a[2], 11, [3] p 300 $aIn verse. 300 $aThe last leaf is blank. 300 $aPossibly intended to be issued with: University of Cambridge. Gratulatio AcademiƦ Cantabrigiensis de serenissimi principis reditu ex Hispaniis exoptatissimo. 300 $aReproduction of the original in Harvard University. Library. 330 $aeebo-0062 700 $aHerbert$b George$f1593-1633.$0167806 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bWaOLN 906 $aBOOK 912 $a996388852203316 996 $aOratio qua? auspicatissimum serenissimi principis Caroli, reditum ex Hispanijs celebrauit Georgius Herbert Academię Cantabrigiensis orator$92386633 997 $aUNISA LEADER 05130nam 22005655 450 001 9910298446603321 005 20220404225906.0 010 $a3-319-22822-6 024 7 $a10.1007/978-3-319-22822-8 035 $a(CKB)3710000000484445 035 $a(EBL)4178510 035 $a(SSID)ssj0001583806 035 $a(PQKBManifestationID)16264415 035 $a(PQKBTitleCode)TC0001583806 035 $a(PQKBWorkID)14864272 035 $a(PQKB)11461556 035 $a(DE-He213)978-3-319-22822-8 035 $a(MiAaPQ)EBC4178510 035 $a(PPN)190531436 035 $a(EXLCZ)993710000000484445 100 $a20150930d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEpstein Barr virus volume 1 $eone herpes virus: many diseases /$fedited by Christian Münz 205 $a1st ed. 2015. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015. 215 $a1 online resource (387 p.) 225 1 $aCurrent Topics in Microbiology and Immunology,$x0070-217X ;$v390 300 $aDescription based upon print version of record. 311 $a3-319-22821-8 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPreface -- History -- Chap. 1 Why and How Epstein-Barr Virus was discovered 50 years ago - Anthony Epstein, University of Oxford, UK -- Chap. 2. Tumor associations of EBV ? historical perspectives - George Klein, Karolinska Institutet, Stockholm, Sweden -- Chap. 3. EBV-specific immune response: early research and personal reminiscences ? Denis J. Moss and Viviana P. Lutzky, Queensland Institute of Medical Research, Brisbane, Australia -- Virus genetics and epigenetics -- Chap. 4. Epstein Barr virus strain variation - Paul J. Farrell, Imperial College, London, UK -- Chap. 5. Chromatin Structure of Epstein-Barr Virus Latent Episomes  ? Paul M. Lieberman, University of Pennsylvania, Philadelphia, USA -- Chap. 6. The epigenetic life cycle of Epstein-Barr virus - Wolfgang Hammerschmidt, Helmholtz Center Munich, Germany. Chap. 7. Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types - Regina Feederle, Olaf Klinke, Anton Kutikhin, Remy Poirey, Ming-Han Tsai and Henri-Jacques Delecluse, German Cancer Research Center, Heidelberg, Germany -- Viral infection and associated diseases -- Chap. 8. EBV persistence ? introducing the virus ? David A. Thorley-Lawson, Tufts University, Boston, USA -- Chap. 9. Infectious mononucleosis ? Samantha K. Dunmire, Kristin A. Hogquist and Henry H. Balfour, Jr., University of Minnesota, Minneapolis, USA -- Chap. 10. Primary immunodeficiencies associated with EBV disease - Jeffrey I. Cohen, National Institutes of Health, Bethesda, USA -- Chap. 11. Burkitt?s lymphoma ? Rosemary Rochford  and Ann M. Moormann, University of Massachusetts, Worcester, and Upstate University of New York, Syracuse, USA -- Chap. 12. Contribution of the Epstein-Barr virus to the pathogenesis of Hodgkin lymphoma ? Paul Murray and Andrew Bell, University of Birmingham, UK -- Chap. 13. The role of EBV in the pathogenesis of diffuse large B cell lymphoma ? Jane A. Healy and Sandeep S. Dave, Duke University, Raleigh, USA -- Chap. 14. Nasopharyngeal carcinoma:  an evolving role for the Epstein Barr virus ? Nancy Raab-Traub, University of North Carolina, Chapel Hill, USA.-Chap. 15. EBV and autoimmunity ? Alberto Ascherio and Kassandra Munger, Harvard University, Boston, USA -- Index. 330 $aEpstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt?s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future. 410 0$aCurrent Topics in Microbiology and Immunology,$x0070-217X ;$v390 606 $aVirology 606 $aVirology$3https://scigraph.springernature.com/ontologies/product-market-codes/B22003 615 0$aVirology. 615 14$aVirology. 676 $a616.9940194 702 $aMünz$b Christian$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910298446603321 996 $aEpstein Barr Virus Volume 1$92513334 997 $aUNINA